David Underwood
CEO & Chairman of the Board
clinical research
UHY Hacker Young
Falkland Islands
Biography
David Underwood is the founding CEO and Chairman of Quanticate. Having previously been the Managing Director for Statwood Ltd for 14 years and taking on the role of chairman for Oxford Pharmaceutical Limited (OPS) in 2002, it was decided in October 2007 to merge the two companies to form Quanticate Ltd. Prior to forming Statwood, David worked for 17 years as a statistician and Global Project Leader for Biostatistics and Data Management at Glaxosmithkline.
Research Interest
Clinical Research
